Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.
Publication
, Other
Moul, JW
Published in: Cancer
August 1, 2009
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cancer
DOI
ISSN
0008-543X
Publication Date
August 1, 2009
Volume
115
Issue
15
Start / End Page
3376 / 3378
Location
United States
Related Subject Headings
- Tosyl Compounds
- Randomized Controlled Trials as Topic
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Nitriles
- Male
- Humans
- Gonadotropin-Releasing Hormone
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents, Hormonal
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W. (2009). Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer. Cancer. United States. https://doi.org/10.1002/cncr.24393
Moul, Judd W. “Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.” Cancer, August 1, 2009. https://doi.org/10.1002/cncr.24393.
Moul JW. Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer. Vol. 115, Cancer. 2009. p. 3376–8.
Moul, Judd W. “Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.” Cancer, vol. 115, no. 15, 1 Aug. 2009, pp. 3376–78. Pubmed, doi:10.1002/cncr.24393.
Moul JW. Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer. Cancer. 2009. p. 3376–3378.
Published In
Cancer
DOI
ISSN
0008-543X
Publication Date
August 1, 2009
Volume
115
Issue
15
Start / End Page
3376 / 3378
Location
United States
Related Subject Headings
- Tosyl Compounds
- Randomized Controlled Trials as Topic
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Nitriles
- Male
- Humans
- Gonadotropin-Releasing Hormone
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents, Hormonal